These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38400841)

  • 21. Controlled precipitation for enhanced dissolution rate of flurbiprofen: development of rapidly disintegrating tablets.
    Essa EA; Elmarakby AO; Donia AMA; El Maghraby GM
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1430-1439. PubMed ID: 28402193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast disintegrating tablets of nisoldipine for intra-oral administration.
    El Maghraby GM; Elsergany RN
    Pharm Dev Technol; 2014 Sep; 19(6):641-50. PubMed ID: 23841582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients.
    Conceição J; Adeoye O; Cabral-Marques H; Concheiro A; Alvarez-Lorenzo C; Sousa Lobo JM
    AAPS PharmSciTech; 2020 Jan; 21(2):39. PubMed ID: 31897724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
    Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
    Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of a significant pharmacokinetic interaction between hydrochlorothiazide and triamterene when coadministered.
    Upton RA; Williams RL; Lin ET; Gee WL; Blume CD; Benet LZ
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):575-86. PubMed ID: 6533293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier.
    Alshaikh RA; Essa EA; El Maghraby GM
    Pharm Dev Technol; 2020 Feb; 25(2):168-177. PubMed ID: 31642728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrophotometric simultaneous determination of triamterene and hydrochlorothiazide in triamterene-H tablets by multivariate calibration methods.
    Kargosha K; Sarrafi AH
    J Pharm Biomed Anal; 2001 Sep; 26(2):273-9. PubMed ID: 11470204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.
    Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS
    Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption and disposition of a new low-dose combination formulation of hydrochlorothiazide and triamterene.
    Williams RL; Lin ET; Liang-Gee W; Blume CD; Benet LZ
    Biopharm Drug Dispos; 1990 Apr; 11(3):233-43. PubMed ID: 2328310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Optimization of Pioglitazone Hydrochloride Self-Nanoemulsifying Drug Delivery System (SNEDDS) Incorporated into an Orally Disintegrating Tablet.
    Teaima M; Hababeh S; Khanfar M; Alanazi F; Alshora D; El-Nabrawi M
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
    Hobbs D; Karagianis J; Treuer T; Raskin J
    Drugs R D; 2013 Dec; 13(4):281-8. PubMed ID: 24170256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
    AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of triamterene and hydrochlorothiazide in tablets using derivative spectrophotometry.
    Stolarczyk M; Apola A; Krzek J; Lech K
    Acta Pol Pharm; 2008; 65(3):283-7. PubMed ID: 18646546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].
    Knauf H; Möhrke W; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):1001-4. PubMed ID: 7191258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets.
    Vlad RA; Antonoaea P; Todoran N; Muntean DL; Rédai EM; Silași OA; Tătaru A; Bîrsan M; Imre S; Ciurba A
    Saudi Pharm J; 2021 Sep; 29(9):1029-1042. PubMed ID: 34588849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous wavelet and derivative transform applied to the overlapping spectra for the quantitative spectrophotometric multi-resolution of triamterene and hydrochlorothiazide in triamterene-H tablets.
    Mohammadpour K; Sohrabi MR; Jourabchi A
    Talanta; 2010 Jun; 81(4-5):1821-5. PubMed ID: 20441980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
    Loke YH; Chew YL; Janakiraman AK; Lee SK; Uddin ABMH; Goh CF; Kee PE; Ng HS; Ming LC; Liew KB
    Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.